2 studies found for:    1003364 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 24-Week Efficacy & Safety Study of Mesafem Capsules in the Treatment of VMS
Condition: Hot Flashes
Intervention: Drug: Mesafem Capsules or Placebo Capsules
2 Completed
Has Results
Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
Condition: Hot Flashes
Interventions: Drug: Brisdelle (paroxetine mesylate);   Drug: Sugar pill

Indicates status has not been verified in more than two years